©The Author(s) 2020.
World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1325-1335
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1325
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1325
Table 1 Main clinicopathological characteristics of patients with circumscribed Borrmann type IV gastric cancer
| Variable | B-4 patients (n = 117) |
| Age (yr) | 57.55 ± 10.69 |
| Gender | |
| Male | 75 |
| Female | 42 |
| Diameter (cm) | 7.81 ± 3.07 |
| Tumor location | |
| Upper 1/3–1/2 (U or MU) | 22 |
| Lower 1/3–1/2 (M or L or ML) | 59 |
| Total (LAU or LMU) | 36 |
| Radical degree | |
| R0 | 45 |
| R1+ | 72 |
| Histological type | |
| Well | 8 |
| Poor | 109 |
| pT stage | |
| pT3 | 36 |
| pT4 | 81 |
| pN stage | |
| pN0 | 22 |
| pN1 | 15 |
| pN2 | 15 |
| pN3 | 65 |
| Venous/lymphatic infiltration | |
| Yes | 74 |
| No | 43 |
| Gastrectomy type | |
| Subtotal gastrectomy | 26 |
| Total gastrectomy | 91 |
| Adjuvant chemotherapy | |
| Yes | 74 |
| No | 43 |
- Citation: Huang HB, Gao ZM, Sun AQ, Liang WT, Li K. Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer. World J Gastrointest Oncol 2020; 12(11): 1325-1335
- URL: https://www.wjgnet.com/1948-5204/full/v12/i11/1325.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i11.1325